Capecitabine (Mylan Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Capecitabine drug offered from Mylan Pharmaceuticals Inc.. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Mylan Pharmaceuticals Inc. |
NON-PROPRIETARY NAME: | capecitabine |
SUBSTANCE NAME: | CAPECITABINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2014-08-08 |
END MARKETING DATE: | 0000-00-00 |
Capecitabine HUMAN PRESCRIPTION DRUG Details:
Item Description | Capecitabine from Mylan Pharmaceuticals Inc. |
LABELER NAME: | Mylan Pharmaceuticals Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 150(mg/1) |
START MARKETING DATE: | 2014-08-08 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0378-2511_069199ca-5268-4f7c-9334-859b392feb3a |
PRODUCT NDC: | 0378-2511 |
APPLICATION NUMBER: | ANDA090943 |
Other CAPECITABINE Pharmaceutical Manufacturers / Labelers: